With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
WHO announces updated influenza vaccine strains for the 2026–27 northern hemisphere season, reflecting evolving flu virus ...
As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well. It had one of its worst effectiveness rates in more than a decade.
The US FDA’s vaccine advisors have recommended that three new influenza strains be included in next winter’s influenza vaccine, aiming in part to tamp down illness caused by subclade K, a mutated form ...
Although the Centers for Disease Control and Prevention (CDC) classifies the current flu season as “moderate,” at least 90 children have already died of influenza. Among the children who died and were ...
A long-running debate in vaccine design revolves around whether a vaccine should be optimized to prevent the virus from ...
Straight Arrow News on MSN
FDA advisers suggest covering highly spreadable subclade K variant in flu vaccines
An FDA advisory committee voted to recommend including a viral strain of the flu, subclade k, in vaccines beginning this fall ...
Flu season might be winding down — but don’t stash the tissues just yet. A little-known respiratory virus with no vaccine or treatment has been quietly picking up steam since the start of winter, ...
CDC data suggest adult vaccination rates are up slightly this season, to 46.5%. An estimated 48% of U.S. kids were vaccinated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results